Canon Medical Systems Group aims to provide products, services and solutions that incorporate elements of sustainability required by modern society. We believe overcoming challenges and providing value in line with a changing world through our business activities will lead to sustainable synergistic development of the company and society.
I see acting with integrity as the foundation of our sustainability efforts. We are transparent in our actions and aim to do what is right, as reflected in our Made for Life philosophy. We also account for our activities in this Annual Corporate Social Responsibility (CSR) report on our achievements and objectives.
2020 and 2021 were challenging years for all of us due to the worldwide COVID-19 pandemic. It will continue to influence activities in 2022 and possibly beyond. I see our greatest achievements as our commitment to the health and safety of employees and our continued contributions to customers in the medical care sector. I am also grateful we could continue supporting communities worldwide. For example, when China faced a shortage of equipment to diagnose lung inflammation related to COVID-19, we were able to donate medical equipment to Wuhan.
Our focus for 2025 is to continue making progress in medical treatment with the aid of medical imaging, and to support the good health and wellbeing of patients together with our partners in scientific and clinical research.
Another challenge we see for society and our company is climate change. We have already been working on reducing CO2 emissions for quite some time by reducing energy use in our organization, generating renewable energy and designing environmentally friendly products that consume less energy.
Many countries and regions have set targets to reach carbon neutrality in 2050. Japan has pledged a 46% reduction in greenhouse gas emissions by 2030, but very little renewable energy is currently available in Japan where our largest production unit is located. Our facilities in the UK use 100% renewable energy and we aim to set a new mid to long-term CO2 reduction target next year for the entire group, including our production and supply chains in Japan, Malaysia, China and Brazil.
President and CEO,
The last challenge I would like to highlight is a better gender balance in our company, as regards both the total workforce and management positions throughout the global group. We aim to further promote the creation of an environment where resourceful, qualified individuals can perform at their full potential regardless of their gender, culture or background.
Finally, a tremendous effort was made by the entire group in gathering information and contributing to the realization of this 2021 Annual CSR Report, which for the first time is based on the sustainability reporting guidelines of the Global Reporting Initiative (GRI). Based on all of the input, we have also been able to determine a new CSR Policy for the entire Canon Medical Systems Group.
- Toshio Takiguchi, President and CEO, Canon Medical Systems Corporation
Our goal is to provide medical professionals with the solutions they need to improve the health and well-being of patients across the globe.
Underpinning this is our corporate philosophy, Made for Life , which inspires us to create technologies that provide faster, more accurate diagnoses, better treatment outcomes and enhanced patient care.
Our philosophy drives us to create a better world for everyone in line with our Corporate Social Responsibility (CSR). Through technological innovation, partnership building and sustainable practices, we are focused on contributing to the 3rd, 8th and 13th Sustainable Development Goals (SDGs) shown on the left.
Toward this end, our key CSR objectives for 2021-2025 are:
Achieve progress in current medical treatments with the support of medical imaging.
Support global initiatives with impact on local communities in the medical field.
Contribute to the battle against climate change.
See the complete Canon Medical Systems Group CSR Policy 2021-2025 here:
Canon Medical Systems Group’s material topics, which form the basis of our CSR Policy, were identified in 2021 through extensive consultations with stakeholders including customers, employees and government authorities. By contributing to the improvement of material topics, we also contribute to several other SDGs, as shown on the right.
To determine the material issues, we took into account our stakeholders’ expectations and degree of association with our business activities:
CSR Report 2021
A CSR Project Team was set up at the beginning of 2021 with representatives from the environment, human resources (HR) and facilities departments. In addition, representatives from 20 of our subsidiaries participated in a global CSR Project Group. They gathered the CSR data on 2020 using the latest generation of GRI Standards from the Global Reporting Initiative. The status regarding all the indicators can be found in the attached GRI Table. The table was checked by The Sustainable Advisors, from the Netherlands.
Scope of the report
This report outlines activities conducted by Canon Medical Systems Group throughout 2020 at our Headquarters in Japan, 20 subsidiaries and 9 group companies located in the following 24 countries and regions: Japan, Malaysia, Singapore, China, Hong Kong, Korea, Turkey, Netherlands, Belgium, Germany, Switzerland, Austria, Sweden, France, Spain, Portugal, Italy, UK, USA, Canada, Brazil, Argentina, Australia and New Zealand.
Environmental information on CO 2 and waste data was used from 22 subsidiaries and group companies.
Please contact our CSR Coordinator if you have any questions about this report: Contact us
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems global webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.